Natus To Present At Upcoming Financial Conferences
Natus Medical Incorporated (Nasdaq:BABY) today announced that the Company is scheduled to present at two upcoming financial conferences.
Jim Hawkins, Chief Executive Officer of the Company, will make a presentation at the Raymond James 33rd Annual Institutional Investors Conference. The conference is being held at the JW Marriott Grande Lakes in Orlando, Florida on March 5-7, 2012. Mr. Hawkins is scheduled to present on Monday, March 5 at 9:15 a.m. Eastern Time (6:15 a.m. PT). Attendance at the Raymond James 33rd Annual Institutional Investors Conference is by invitation only.
Mr. Hawkins and Steven J. Murphy, Vice President Finance and Chief Financial Officer of the Company, will attend the Roth Capital Partners 24th Annual OC Growth Stock Conference. The conference is being held at the Ritz-Carlton Hotel, Laguna Niguel, California on March 11-14, 2012. Mr. Hawkins is scheduled to make a presentation on Monday, March 12 at 10:00 a.m. Pacific Time (1:00 p.m. ET). Attendance at the Roth Capital Partners 24th Annual OC Growth Stock Conference is by invitation only.
Investors may listen to a live webcast and view a copy of the slide presentation online via the “Investors” section of the Company’s web site at http://investor.natus.com. The recorded webcasts will be accessible online for at least 30 days.
About Natus Medical Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
